Functional, molecular and pharmacological advances in 5-HT7 receptor research.

The 5-HT7 receptor was among a group of 5-HT receptors that were discovered using targeted cloning strategies 12 years ago. This receptor is a seven-transmembrane-domain G-protein-coupled receptor that is positively linked to adenylyl cyclase. The distributions of 5-HT7 receptor mRNA, immunolabeling and radioligand binding exhibit strong similarities, with the highest receptor densities present in the thalamus and hypothalamus and significant densities present in the hippocampus and cortex. The recent availability of selective antagonists and knockout mice strains has dramatically increased our knowledge about this receptor. Together with unselective agonists, these new tools have helped to reveal the 5-HT7 receptor distribution in more detail. Important functional roles for the 5-HT7 receptor in thermoregulation, circadian rhythm, learning and memory, hippocampal signaling and sleep have also been established. Hypotheses driving current research indicate that this receptor might be involved in mood regulation, suggesting that the 5-HT7 receptor is a putative target in the treatment of depression.

[1]  J. Neumaier,et al.  Localization of 5-HT7 receptors in rat brain by immunocytochemistry, in situ hybridization, and agonist stimulated cFos expression , 2001, Journal of Chemical Neuroanatomy.

[2]  M. Takigawa,et al.  5-Hydroxytryptamine7 (5-HT7) receptor immunoreactivity-positive ‘stigmoid body’-like structure in developing rat brains , 2003, International Journal of Developmental Neuroscience.

[3]  C. Davies,et al.  5-HT7 receptors modulate synchronized network activity in rat hippocampus , 2002, Neuropharmacology.

[4]  D. Middlemiss,et al.  [3 H]-SB-269970 radiolabels 5-HT7 receptors in rodent, pig and primate brain tissues , 2002, Neuropharmacology.

[5]  D. S. Cowen,et al.  5-HT(7) receptors activate the mitogen activated protein kinase extracellular signal related kinase in cultured rat hippocampal neurons. , 2001, Neuroscience.

[6]  S. Ying,et al.  5-HT7 receptors mediate serotonergic effects on light-sensitive suprachiasmatic nucleus neurons , 1997, Brain Research.

[7]  P J Lovell,et al.  (R)-3,N-dimethyl-N-[1-methyl-3-(4-methyl-piperidin-1-yl) propyl]benzenesulfonamide: the first selective 5-HT7 receptor antagonist. , 1998, Journal of medicinal chemistry.

[8]  T. Kitazawa,et al.  5-HT7 receptor-mediated relaxation of the oviduct in nonpregnant proestrus pigs. , 2003, European journal of pharmacology.

[9]  G. Mcallister,et al.  The hypothermic effect of 5-CT in mice is mediated through the 5-HT7 receptor , 2003, Neuropharmacology.

[10]  M. Leopoldo.  Serotonin(7) receptors (5-HT(7)Rs) and their ligands. , 2004, Current medicinal chemistry.

[11]  P. Osborne,et al.  Opposing electrophysiological actions of 5-HT on noncholinergic and cholinergic neurons in the rat ventral pallidum in vitro. , 2004, Journal of neurophysiology.

[12]  Daniel Hoyer,et al.  Molecular, pharmacological and functional diversity of 5-HT receptors , 2002, Pharmacology Biochemistry and Behavior.

[13]  J. Schwartz,et al.  Molecular cloning, characterization, and localization of a high-affinity serotonin receptor (5-HT7) activating cAMP formation. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[14]  M. Meaney,et al.  Serotonin regulates hippocampal glucocorticoid receptor expression via a 5-HT7 receptor. , 2002, Brain research. Developmental brain research.

[15]  G. Sanger,et al.  Evidence for the involvement of central 5‐HT7 receptors in the micturition reflex in anaesthetized female rats , 2003, British journal of pharmacology.

[16]  T. Branchek,et al.  Cloning of a novel human serotonin receptor (5-HT7) positively linked to adenylate cyclase. , 1993, The Journal of biological chemistry.

[17]  D. Sibley,et al.  Binding of typical and atypical antipsychotic agents to 5-hydroxytryptamine-6 and 5-hydroxytryptamine-7 receptors. , 1994, The Journal of pharmacology and experimental therapeutics.

[18]  J. Seckl,et al.  Acute restraint stress increases 5-HT7 receptor mRNA expression in the rat hippocampus , 2001, Neuroscience Letters.

[19]  D. S. Cowen,et al.  Coupling of neuronal 5‐HT7 receptors to activation of extracellular‐regulated kinase through a protein kinase A‐independent pathway that can utilize Epac , 2003, Journal of neurochemistry.

[20]  E. Lacivita,et al.  Studies on 1‐arylpiperazine derivatives with affinity for rat 5‐HT7 and 5‐HT1A receptors , 2004, The Journal of pharmacy and pharmacology.

[21]  Karrie E Grear,et al.  Aging and SB-269970-A, a selective 5-HT7 receptor antagonist, attenuate circadian phase advances induced by microinjections of serotonergic drugs in the hamster dorsal raphe nucleus , 2004, Brain Research.

[22]  K. Krobert,et al.  The human 5‐HT7 serotonin receptor splice variants: constitutive activity and inverse agonist effects , 2002, British journal of pharmacology.

[23]  R. Naylor,et al.  5‐HT7 receptors mediate the inhibitory effect of 5‐HT on peristalsis in the isolated guinea‐pig ileum , 2003, British journal of pharmacology.

[24]  M. Erlander,et al.  A novel adenylyl cyclase-activating serotonin receptor (5-HT7) implicated in the regulation of mammalian circadian rhythms , 1993, Neuron.

[25]  E. Setiawan,et al.  Developmental regulation of the 5‐HT7 serotonin receptor and transcription factor NGFI‐A in the fetal guinea‐pig limbic system: influence of GCs , 2004, The Journal of physiology.

[26]  Y Anouar,et al.  Pharmacological and molecular characterization of 5-hydroxytryptamine(7) receptors in the rat adrenal gland. , 1999, Molecular pharmacology.

[27]  E. Hamel,et al.  Serotonin 5-HT(7) receptors mediate relaxation of porcine pial veins. , 2000, American journal of physiology. Heart and circulatory physiology.

[28]  A. Eison,et al.  Effects of Antidepressants on 5-HT7 Receptor Regulation in the Rat Hypothalamus , 1999, Neuropsychopharmacology.

[29]  Ronan Bureau,et al.  Molecular Design Based on 3D Pharmacophores. Applications to 5-HT7 Receptors , 2004, J. Chem. Inf. Model..

[30]  J. Hagan,et al.  [3H]‐SB‐269970 – A selective antagonist radioligand for 5‐HT7 receptors , 2000 .

[31]  J. Plassat,et al.  Molecular cloning of a mammalian serotonin receptor that activates adenylate cyclase. , 1993, Molecular pharmacology.

[32]  P. Bonaventure,et al.  8-OH-DPAT acts on both 5-HT1A and 5-HT7 receptors to induce hypothermia in rodents. , 2004, European journal of pharmacology.

[33]  K. Fuxe,et al.  EVIDENCE FOR THE EXISTENCE OF MONOAMINE-CONTAINING NEURONS IN THE CENTRAL NERVOUS SYSTEM. I. DEMONSTRATION OF MONOAMINES IN THE CELL BODIES OF BRAIN STEM NEURONS. , 1964, Acta physiologica Scandinavica. Supplementum.

[34]  A. Meneses,et al.  8-OH-DPAT facilitated memory consolidation and increased hippocampal and cortical cAMP production , 2004, Behavioural Brain Research.

[35]  Ulf Bickmeyer,et al.  Differential modulation of Ih by 5‐HT receptors in mouse CA1 hippocampal neurons , 2002, The European journal of neuroscience.

[36]  J. Hagan,et al.  SB‐656104‐A, a novel selective 5‐HT7 receptor antagonist, modulates REM sleep in rats , 2003, British journal of pharmacology.

[37]  D. W. Lee,et al.  In vitro expression and pharmacology of the 5‐HT7‐like receptor present in the mosquito Aedes aegypti tracheolar cells and hindgut‐associated nerves , 2003, Insect molecular biology.

[38]  Grzegorz Hess,et al.  5-HT7 receptors increase the excitability of rat hippocampal CA1 pyramidal neurons , 2003, Brain Research.

[39]  J. Terrón,et al.  Pharmacological evidence for the 5‐HT7 receptor mediating smooth muscle relaxation in canine cerebral arteries , 1999, British journal of pharmacology.

[40]  R. Andrade,et al.  Serotonergic facilitation of synaptic activity in the developing rat prefrontal cortex , 2004, The Journal of physiology.

[41]  R. Jakus,et al.  Selective 5-HT1A and 5-HT7 antagonists decrease epileptic activity in the WAG/Rij rat model of absence epilepsy , 2004, Neuroscience Letters.

[42]  H. Nagaso,et al.  Tetrahydrobenzindoles: selective antagonists of the 5-HT7 receptor. , 1999, Journal of medicinal chemistry.

[43]  F. Levy,et al.  Functional 5-HT receptors in human occipital artery , 2004, Naunyn-Schmiedeberg's Archives of Pharmacology.

[44]  Xavier Langlois,et al.  Reconsideration of 5-hydroxytryptamine (5-HT)(7) receptor distribution using [(3)H]5-carboxamidotryptamine and [(3)H]8-hydroxy-2-(di-n-propylamino)tetraline: analysis in brain of 5-HT(1A) knockout and 5-HT(1A/1B) double-knockout mice. , 2002, The Journal of pharmacology and experimental therapeutics.

[45]  T. Branchek,et al.  A receptor autoradiographic and in situ hybridization analysis of the distribution of the 5‐ht7 receptor in rat brain , 1996, British journal of pharmacology.

[46]  C. Marsden,et al.  Antisense Oligonucleotide‐Induced Reduction in 5‐Hydroxytryptamine7 Receptors in the Rat Hypothalamus Without Alteration in Exploratory Behaviour or Neuroendocrine Function , 1998, Journal of neurochemistry.

[47]  D. S. Cowen,et al.  5-HT7 receptors activate the mitogen activated protein kinase extracellular signal related kinase in cultured rat hippocampal neurons , 2001, Neuroscience.

[48]  S. Beck,et al.  5-Hydroxytryptamine(7) receptor activation decreases slow afterhyperpolarization amplitude in CA3 hippocampal pyramidal cells. , 2000, The Journal of pharmacology and experimental therapeutics.

[49]  A. Kjaer,et al.  Serotonin Receptors Involved in Vasopressin and Oxytocin Secretion , 2003, Journal of neuroendocrinology.

[50]  L. Pardo,et al.  Optimization of the pharmacophore model for 5-HT7R antagonism. Design and synthesis of new naphtholactam and naphthosultam derivatives. , 2003, Journal of medicinal chemistry.

[51]  P. Kelly,et al.  Differential regulation of corticosteroid receptors by monoamine neurotransmitters and antidepressant drugs in primary hippocampal culture , 2003, Neuroscience.

[52]  Jun Li,et al.  [Association of 5-HT(2A) receptor polymorphism and attention deficit hyperactivity disorder in children]. , 2002, Zhonghua yi xue za zhi.

[53]  Guang-di Yu,et al.  The inhibitory effect of serotonin on the spontaneous discharge of suprachiasmatic neurons in hypothalamic slice is mediated by 5-HT7 receptor , 2001, Brain Research Bulletin.

[54]  I. Forbes.  (R)‐3,N‐Dimethyl‐N‐ [1‐methyl‐3‐(4‐methylpiperidin‐1‐yl)propyl]benzenesulfonamide: The First Selective 5‐HT7 Receptor Antagonist. , 1998 .

[55]  D. Schmidt-Grimminger,et al.  Presence of a 5-HT7 receptor positively coupled to adenylate cyclase activation in human granulosa-lutein cells. , 2000, The Journal of clinical endocrinology and metabolism.

[56]  J. Sutcliffe,et al.  No hypothermic response to serotonin in 5-HT7 receptor knockout mice , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[57]  J. Ehlen,et al.  In Vivo Resetting of the Hamster Circadian Clock by 5-HT7 Receptors in the Suprachiasmatic Nucleus , 2001, The Journal of Neuroscience.

[58]  Ronan Bureau,et al.  Molecular Design Based on 3D-Pharmacophore. Application to 5-HT4 Receptor , 2002, J. Chem. Inf. Comput. Sci..

[59]  J. Sutcliffe,et al.  Mice lacking 5‐HT7 receptors show specific impairments in contextual learning , 2004, The European journal of neuroscience.

[60]  J. Palacios,et al.  5-HT receptors in mammalian brain: receptor autoradiography andin situ hybridization studies of new ligands and newly identified receptors , 1996, The Histochemical Journal.

[61]  E. Schutter,et al.  Localization of 5-HT2A, 5-HT3, 5-HT5A and 5-HT7 receptor-like immunoreactivity in the rat cerebellum , 2002, Journal of Chemical Neuroanatomy.

[62]  G. E. Pickard,et al.  Response of the Mouse Circadian System to Serotonin 1A/2/7 Agonists in vivo: Surprisingly Little , 2003, Journal of biological rhythms.

[63]  J. Hagan,et al.  Characterization of SB‐269970‐A, a selective 5‐HT7 receptor antagonist , 2000, British journal of pharmacology.

[64]  Robert J. Hobson,et al.  SER‐7b, a constitutively active Gαs coupled 5‐HT7‐like receptor expressed in the Caenorhabditis elegans M4 pharyngeal motorneuron , 2003, Journal of neurochemistry.

[65]  J. Hagan,et al.  5-HT7 receptor subtype as a mediator of the serotonergic regulation of luteinizing hormone release in the zona incerta. , 2004, European journal of pharmacology.

[66]  P. Szot,et al.  Function and distribution of three rat 5-hydroxytryptamine7 (5-HT7) receptor isoforms produced by alternative splicing , 1998, Neuropharmacology.

[67]  J. Hagan,et al.  5-HT7 receptors. , 2004, Current drug targets. CNS and neurological disorders.

[68]  P. Bonaventure,et al.  Radioligand binding analysis of knockout mice reveals 5-hydroxytryptamine7 receptor distribution and uncovers 8-hydroxy-2-(di-n-propylamino)tetralin interaction with α2 adrenergic receptors , 2004, Neuroscience.

[69]  Á. Pazos,et al.  Autoradiographic distribution of 5‐HT7 receptors in the human brain using [3H]mesulergine: comparison to other mammalian species , 2004, British journal of pharmacology.

[70]  J. Sprouse,et al.  8-OH-DPAT as a 5-HT7 agonist: phase shifts of the circadian biological clock through increases in cAMP production , 2004, Neuropharmacology.

[71]  J. Norum,et al.  Ras-dependent ERK Activation by the Human Gs-coupled Serotonin Receptors 5-HT4(b) and 5-HT7(a) * , 2003, The Journal of Biological Chemistry.

[72]  M. Beer,et al.  Thiazoles and thiopyridines: novel series of high affinity h5HT(7) ligands. , 2004, Bioorganic & medicinal chemistry letters.

[73]  S. Shibata,et al.  Nonphotic Entrainment by 5-HT1A/7 Receptor Agonists Accompanied by Reduced Per1 and Per2 mRNA Levels in the Suprachiasmatic Nuclei , 2000, The Journal of Neuroscience.

[74]  L. Dinardo,et al.  Midbrain Raphe Modulation of Nonphotic Circadian Clock Resetting and 5-HT Release in the Mammalian Suprachiasmatic Nucleus , 2003, The Journal of Neuroscience.

[75]  J. Kew,et al.  GABAergic modulation of 5-HT7 receptor-mediated effects on 5-HT efflux in the guinea-pig dorsal raphe nucleus , 2004, Neuropharmacology.

[76]  G. E. Pickard,et al.  Subcellular distribution of 5‐HT1b and 5‐HT7 receptors in the mouse suprachiasmatic nucleus , 2001, The Journal of comparative neurology.

[77]  K. Krobert,et al.  Unaltered agonist potency upon inducible 5-HT7(a) but not 5-HT4(b) receptor expression indicates agonist-independent association of 5-HT7(a) receptor and Gs. , 2003, Receptors & channels.